202 related articles for article (PubMed ID: 29950151)
21. [Expression and clinical significance of PI3K in esophageal squamous cell carcinoma].
Zhang Y; Liu YP; Du K; Wang H; Wang XL
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):594-8. PubMed ID: 22325219
[TBL] [Abstract][Full Text] [Related]
22. [The association between the whole blood riboflavin level and the occurrence, development and prognosis of esophageal squamous cell carcinoma].
Li SS; Tan HZ; Xu YW; Wu ZY; Wu JY; Zhao XK; Wang LD; Long L; Li EM; Xu LY; Zhang JJ
Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Nov; 53(11):1124-1129. PubMed ID: 31683399
[No Abstract] [Full Text] [Related]
23. The Role of
Xu X; Yang X; Liu X; Bi Y; Kong P; Wang Y; Cheng X; Xi Y
Technol Cancer Res Treat; 2022; 21():15330338221083105. PubMed ID: 35244467
[No Abstract] [Full Text] [Related]
24. Clinical study on lymph node metastatic recurrence in patients with N0 esophageal squamous cell cancer.
Sun ZG; Wang Z
Dis Esophagus; 2011 Apr; 24(3):182-8. PubMed ID: 21073618
[TBL] [Abstract][Full Text] [Related]
25. Elevated levels of serum nidogen-2 in esophageal squamous cell carcinoma.
Chai AWY; Cheung AKL; Dai W; Ko JMY; Lee NPY; Chan KT; Law SY; Lung ML
Cancer Biomark; 2018 Feb; 21(3):583-590. PubMed ID: 29278876
[TBL] [Abstract][Full Text] [Related]
26. Gli1, a potential regulator of esophageal cancer stem cell, is identified as an independent adverse prognostic factor in esophageal squamous cell carcinoma.
Yang Z; Cui Y; Ni W; Kim S; Xuan Y
J Cancer Res Clin Oncol; 2017 Feb; 143(2):243-254. PubMed ID: 27680978
[TBL] [Abstract][Full Text] [Related]
27. Eriodictyol suppresses the malignant progression of colorectal cancer by downregulating tissue specific transplantation antigen P35B (TSTA3) expression to restrain fucosylation.
Huang H; He Y; Li Y; Gu M; Wu M; Ji L
Bioengineered; 2022 Mar; 13(3):5551-5563. PubMed ID: 35184647
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of pituitary tumor transforming gene (PTTG) is associated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma.
Zhang J; Yang Y; Chen L; Zheng D; Ma J
Acta Histochem; 2014 Apr; 116(3):435-9. PubMed ID: 24176776
[TBL] [Abstract][Full Text] [Related]
29. The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features.
Wang WS; Zhong HJ; Xiao DW; Huang X; Liao LD; Xie ZF; Xu XE; Shen ZY; Xu LY; Li EM
Dis Esophagus; 2010 Aug; 23(6):512-21. PubMed ID: 20095995
[TBL] [Abstract][Full Text] [Related]
30. Prognostic relevance of Id-1 expression in patients with resectable esophageal squamous cell carcinoma.
Luo KJ; Wen J; Xie X; Fu JH; Luo RZ; Wu QL; Hu Y
Ann Thorac Surg; 2012 May; 93(5):1682-8. PubMed ID: 22480390
[TBL] [Abstract][Full Text] [Related]
31. Aberrant overexpression of EZH2 and H3K27me3 serves as poor prognostic biomarker for esophageal squamous cell carcinoma patients.
Liu F; Gu L; Cao Y; Fan X; Zhang F; Sang M
Biomarkers; 2016; 21(1):80-90. PubMed ID: 26631178
[TBL] [Abstract][Full Text] [Related]
32. JMJD3 expression is an independent prognosticator in patients with esophageal squamous cell carcinoma.
Li SH; Lu HI; Chen YH; Lo CM; Huang WT; Tien WY; Lan YC; Tsai HT; Chen CH
Surgery; 2019 May; 165(5):946-952. PubMed ID: 30678869
[TBL] [Abstract][Full Text] [Related]
33. High levels of RAI3 expression is linked to shortened survival in esophageal cancer patients.
El Gammal AT; Melling N; Reeh M; Gebauer F; Mann O; Perez D; Bockhorn M; Bachmann K; Izbicki JR; Grupp K
Exp Mol Pathol; 2019 Apr; 107():51-56. PubMed ID: 30707896
[TBL] [Abstract][Full Text] [Related]
34. FUCA2 and TSTA3 expression in gastric cancer: candidate biomarkers of malignant transformation.
Leal Quirino MW; Albuquerque APB; de Souza MFD; Filho AFDS; Martins MR; Pitta MGDR; Pereira MC; de Melo MJB
Folia Histochem Cytobiol; 2022; 60(4):335-343. PubMed ID: 36583336
[TBL] [Abstract][Full Text] [Related]
35. Metastatic lymph node CHIP expression is a potential prognostic marker for resected esophageal squamous cell carcinoma patients.
Wen J; Luo KJ; Hu Y; Yang H; Fu JH
Ann Surg Oncol; 2013 May; 20(5):1668-75. PubMed ID: 23429937
[TBL] [Abstract][Full Text] [Related]
36. PD1
Lu Y; Guo L; Ding G
Future Oncol; 2019 Dec; 15(35):4019-4030. PubMed ID: 31612729
[No Abstract] [Full Text] [Related]
37. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma.
He Z; Yi J; Jin L; Pan B; Chen L; Song H
Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958
[TBL] [Abstract][Full Text] [Related]
38. Cytotoxic T lymphocyte antigen-4 expression in esophageal carcinoma: implications for prognosis.
Zhang XF; Pan K; Weng DS; Chen CL; Wang QJ; Zhao JJ; Pan QZ; Liu Q; Jiang SS; Li YQ; Zhang HX; Xia JC
Oncotarget; 2016 May; 7(18):26670-9. PubMed ID: 27050369
[TBL] [Abstract][Full Text] [Related]
39. Intronic polymorphisms in genes LRFN2 (rs2494938) and DNAH11 (rs2285947) are prognostic indicators of esophageal squamous cell carcinoma.
Wang J; Wang Q; Wei B; Zhou Y; Qian Z; Gao Y; Chen X
BMC Med Genet; 2019 May; 20(1):72. PubMed ID: 31053115
[TBL] [Abstract][Full Text] [Related]
40. SLC39A6: a potential target for diagnosis and therapy of esophageal carcinoma.
Cui XB; Shen YY; Jin TT; Li S; Li TT; Zhang SM; Peng H; Liu CX; Li SG; Yang L; Li N; Hu JM; Jiang JF; Li M; Liang WH; Li Y; Wei YT; Sun ZZ; Wu CY; Chen YZ; Li F
J Transl Med; 2015 Oct; 13():321. PubMed ID: 26444413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
